948 related articles for article (PubMed ID: 3520315)
1. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
[TBL] [Abstract][Full Text] [Related]
2. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
[TBL] [Abstract][Full Text] [Related]
3. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Ziesche S; Cobb FR; Cohn JN; Johnson G; Tristani F
Circulation; 1993 Jun; 87(6 Suppl):VI56-64. PubMed ID: 8500241
[TBL] [Abstract][Full Text] [Related]
4. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
[TBL] [Abstract][Full Text] [Related]
5. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
[TBL] [Abstract][Full Text] [Related]
6. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
Ghose JC; Chakraborty S; Mondal M; Bhandari B
J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
[TBL] [Abstract][Full Text] [Related]
7. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.
Johnson G; Carson P; Francis GS; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI32-9. PubMed ID: 8500237
[TBL] [Abstract][Full Text] [Related]
8. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
Cohn JN; Johnson G; Ziesche S; Cobb F; Francis G; Tristani F; Smith R; Dunkman WB; Loeb H; Wong M
N Engl J Med; 1991 Aug; 325(5):303-10. PubMed ID: 2057035
[TBL] [Abstract][Full Text] [Related]
9. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.
Fletcher RD; Cintron GB; Johnson G; Orndorff J; Carson P; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI49-55. PubMed ID: 8500239
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Cintron G; Johnson G; Francis G; Cobb F; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI17-23. PubMed ID: 8500235
[TBL] [Abstract][Full Text] [Related]
11. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
Carson PE; Johnson GR; Dunkman WB; Fletcher RD; Farrell L; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI102-10. PubMed ID: 8500233
[TBL] [Abstract][Full Text] [Related]
12. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
13. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
Cohn JN
Eur Heart J; 1988 Jan; 9 Suppl A():171-3. PubMed ID: 3044793
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group.
Goldman S; Johnson G; Cohn JN; Cintron G; Smith R; Francis G
Circulation; 1993 Jun; 87(6 Suppl):VI24-31. PubMed ID: 8500236
[TBL] [Abstract][Full Text] [Related]
15. Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure.
Cohn JN
Herz; 1991 Sep; 16 Spec No 1():267-71. PubMed ID: 1820292
[TBL] [Abstract][Full Text] [Related]
16. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).
Carson P; Johnson G; Fletcher R; Cohn J
J Am Coll Cardiol; 1996 Mar; 27(3):642-9. PubMed ID: 8606276
[TBL] [Abstract][Full Text] [Related]
17. Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate.
Adigun AQ; Ajayi OE; Sofowora GG; Ajayi AA
Int J Cardiol; 1998 Nov; 67(1):81-6. PubMed ID: 9880204
[TBL] [Abstract][Full Text] [Related]
18. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
[TBL] [Abstract][Full Text] [Related]
19. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
Taylor AL; Ziesche S; Yancy C; Carson P; D'Agostino R; Ferdinand K; Taylor M; Adams K; Sabolinski M; Worcel M; Cohn JN;
N Engl J Med; 2004 Nov; 351(20):2049-57. PubMed ID: 15533851
[TBL] [Abstract][Full Text] [Related]
20. Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition.
Verma SP; Silke B; Reynolds GW; Kelly JG; Richmond A; Taylor SH
J Cardiovasc Pharmacol; 1992 Aug; 20(2):274-81. PubMed ID: 1381019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]